New pharmaceutical composition for drug delivery
AssigneeOrexo AB
InventorsJonas SÄVMARKER, Robert RÖNN, Andreas FISCHER
Life of this patent
Estimating the term…
Loading patent…
AssigneeOrexo AB
InventorsJonas SÄVMARKER, Robert RÖNN, Andreas FISCHER
Estimating the term…
According to the invention, there is provided a pharmaceutically-acceptable composition which is preferably in the form of a spray-dried powder comprising a mixture of: (a) a pharmacologically-effective dosage amount of at least one pharmaceutically-active compound; and (b) a pharmaceutically-acceptable carrier material, which carrier material comprises a combination of a disaccharide and a polymeric material. Compositions are suitable for, for example, transmucosal drug delivery, including sublingual and nasal delivery. In the case of nasal delivery, said compositions may be loaded into single- or multiple-use nasal applicators. Preferred pharmaceutically-acceptable carriers in this regard include lactose or trehalose and dextrins (e.g. cyclodextrins or maltodextrins), which may be spray-dried together in combination. Compositions may further comprise one or more alkyl saccharides. Preferred alkyl saccharides include sucrose esters, such as sucrose monolaurate.
A pharmaceutically-acceptable composition, which composition is in the form of an amorphous powder comprising:
A manufacturing process comprising the steps of:
Dependencies are inferred from the claim text.